For women with a prior low transverse incision cesarean delivery, the decision to undergo a vaginal delivery or elect to have a repeat cesarean delivery has important clinical and economic ramifications.
Priming the body to respond to immunotherapy with a new class of drugs: epigenetic modifiers.
UAB researchers hope to establish Cialis as a therapeutic agent for pregnant women exposed to chlorine and bromine during industrial accidents or acts of terrorism.
Patients using Botox A for urinary incontinence show higher satisfaction with treatment due to greater reduction in bothersome symptoms.
The change of practice in C-section delivery improves the health of mom and baby.
UAB will help investigate the influence of environmental exposures on children’s health from conception through early childhood.
The UAB Comprehensive Cancer Center has initiated a joint call for action from Alabama organizations urging HPV vaccine for children.
UAB continues to improve maternal and infant health as the only university to be a member of all three NIH perinatal networks.
Joseph Biggio, M.D., is the first to hold the endowed position in maternal-fetal medicine named for John Hauth, who directed the division for more than 10 years.
A UAB physician provides information on risks, recommendations and effects of Zika virus for pregnant women.